Key statistics
On Friday, Camurus AB (7CA:BER) closed at 60.65, -3.27% below its 52-week high of 62.70, set on Sep 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 60.65 |
---|---|
High | 60.65 |
Low | 60.65 |
Bid | 60.30 |
Offer | 60.75 |
Previous close | 59.90 |
Average volume | 89.80 |
---|---|
Shares outstanding | 59.66m |
Free float | 34.89m |
P/E (TTM) | 74.57 |
Market cap | 40.75bn SEK |
EPS (TTM) | 9.16 SEK |
Data delayed at least 15 minutes, as of Jul 11 2025 07:08 BST.
More ▼
- Camurus' Oczyesa® receives marketing authorization for treatment of acromegaly in the EU
- Camurus' Oczyesa® receives marketing authorization for treatment of acromegaly in the EU
- Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients
- Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients
- Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins
- Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins
- CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU
- CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU
More ▼